Quest Diagnostics (DGX) total liabilities

Total liabilities · fiscal 2025
$8.94B

Quest Diagnostics (DGX) had total liabilities of $8.94B at the end of fiscal 2025 (December 31, 2025). That is 3.4% lower than the $9.26B of fiscal 2024. Figures as of 19 Nov 2026, 07:39 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$8.94B
Change on fiscal 2024
−3.4%
Highest on record
$9.26Bfiscal 2024
Lowest on record
$6.83Bfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Quest Diagnostics total liabilities, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $9.26B in fiscal 2024 and the lowest $6.83B in fiscal 2022.

History · 4 fiscal years

Total liabilities by fiscal year

Quest Diagnostics total liabilities, year by year

Quest Diagnostics (DGX) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$8.94B 3.4% down
2024$9.26B 21.7% up
2023$7.60B 11.3% up
2022$6.83B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Quest Diagnostics and comparable companies
CompanyTotal liabilitiesFiscal year
Labcorp Holdings LH$9.76B2025
DexCom DXCM$3.59B2025
Koninklijke Philips PHG€15.96B2025
Roivant Sciences ROIV$416.28M2026
West Pharmaceutical Services WST$1.09B2025
Quest Diagnostics DGX$8.94B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on DGX

Quest Diagnostics, figure by figure

Quest Diagnostics (DGX) overview: price, valuation and scorecardAll health care companies by market value

Quest Diagnostics total liabilities: questions and answers

How large are Quest Diagnostics's total liabilities?

Quest Diagnostics (DGX) had total liabilities of $8.94B at the end of fiscal 2025 (December 31, 2025). That is 3.4% lower than the $9.26B of fiscal 2024.

What are the highest and lowest total liabilities figures on record for Quest Diagnostics?

Across the 4 fiscal years on record (2022–2025), the highest was $9.26B in fiscal 2024 and the lowest $6.83B in fiscal 2022.

How is Quest Diagnostics's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Quest Diagnostics it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Quest Diagnostics (DGX) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/DGX/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.